Navigation Links
Lauren Sciences LLC awarded second Michael J. Fox Foundation grant to further develop V-Smart™ Therapeutic for Parkinson's disease
Date:6/24/2013

New York, N.Y., June 25, 2013 -- Lauren Sciences LLC, a privately-held biotechnology company continuing development of its novel V-Smart platform technology, announced today the award of a second grant by The Michael J. Fox Foundation for Parkinson's Research (MJFF). The company recently completed the first stage of developing V-Smart-based therapeutics for the treatment of Parkinson's disease (PD), which was funded by MJFF, whereby it demonstrated targeted delivery of GDNF (glial-derived neurotrophic factor) to the substantia nigra and the striatum, brain regions in which neurons degenerate during the course of PD. Targeted delivery of GDNF to these brain regions was achieved by systemic administration of the company's V-Smart nanovesicles that were customized for GDNF delivery. The new MJFF grant has been awarded to investigate efficacy of the V-Smart vesicles in a PD animal model.

"We thank The Michael J. Fox Foundation for their second award to us," said Susan Rosenbaum, J.D., Chairman and Chief Executive Officer of Lauren Sciences. "This new MJFF grant has been awarded following the success of our Parkinson's disease project over the past year, and provides recognition of our innovative V-Smart drug delivery system and its potential to transform the treatment of Parkinson's disease with an effective therapeutic that overcomes the historical challenge of developing drugs that cross the blood brain barrier."

"The delivery method of trophic factors continues to be a challenge in reaching the regions of the brain where neuroprotection and repair is needed," said Jamie Eberling, Ph.D., Senior Associate Director of Research Programs at MJFF. "We are looking forward to seeing if V-Smart is proven effective in the delivery of GDNF as a potential disease-modifying therapy for Parkinson's disease."

"Optimized V-Smart vesicles formulated with GDNF have promise as a new treatment for patients," said Irwin Hollander, Ph.D., Vice President, Research and Development, Lauren Sciences. "We hope it will be able to stop progression of, or reverse, Parkinson's disease, unlike other drugs that provide merely symptomatic relief. It is anticipated that the successful outcome of efficacy studies of our GDNF-loaded V-Smart vesicles in Parkinson's pre-clinical models could lead to future clinical studies in Parkinson's disease patients."

"Our latest studies demonstrate that the novel V-Smart nanovesicles can encapsulate GDNF, cross the BBB and release the encapsulated GDNF in areas of the brain affected by Parkinson's," said Eliahu Heldman, Ph.D., Chief Scientific Officer of Lauren Sciences. "Our next goal is to demonstrate that GDNF delivered by V-Smart vesicles is capable of protecting dopaminergic neurons from degeneration in animal model of PD. The success of this project would be an important milestone in the development of GDNF-based therapy for PD that would considerably improve Parkinson's patients' lives."


'/>"/>

Contact: Susan Rosenbaum
srosenbaum@laurensciences.com
212-737-0455
Lauren Sciences LLC
Source:Eurekalert

Related medicine news :

1. Lauren Sciences independently recognized as a Technology Innovator in Drug Delivery with its V-Smart™ Platform, and selected as a Featured Company, in new report by MCD Group
2. Lauren Sciences LLCs research team at Ben-Gurion University awarded Campbell Foundation grant to develop a V-Smart therapeutic for neuro-HIV
3. esyringe® Celebrates Expansion in Life Sciences Sector
4. Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center
5. NYU Professor Li named Pew Scholar in Biomedical Sciences
6. The Neurosciences Institute at Abington Memorial Hospital Opens Multiple Sclerosis Center
7. Applied Protein Sciences Acquired by IndUS Pharmaceuticals
8. Dr. Andrew Cohen of ProActive Chiropractic Recaps the 2013 Chiropractic Sports Sciences Symposium
9. Charm Sciences ROSA® One-Minute Beta-lactam Test and Charm EZ® Reader Validated by ILVO-T&V Belgium
10. KORT's Athletic Training Program at Central High School Sends Student to National Health Sciences Competition
11. Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... Abilene, Texas (PRWEB) , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... says, reveals which name the Creator responds to and which He does not. Yisrayl ... to believe which one is the true name, but he says with a little Scripture, ...
(Date:4/28/2017)... LAKE CITY, UTAH (PRWEB) , ... April 28, ... ... Côté as Account Manager for the North East region. Côté has 20+ years ... and consulting. Prior to Phytomer, Côté worked with an array of high-end cosmetic ...
(Date:4/28/2017)... New York (PRWEB) , ... April 28, 2017 ... ... anti-aging skincare and advanced nutraceutical supplements, through its Nova Skin Sciences ... provides the hydrating benefits of a moisturizer with the power of an anti-aging ...
(Date:4/28/2017)... ... ... Lowe is a popular actor that has been in many different movies and television ... host of the “Informed” series. The program focuses on many important issues that society ... thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, people still ...
(Date:4/28/2017)... ... 28, 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Braun Medical Inc. , a leader in infusion therapy and pain management. , ... 90 percent of hospital patients receiving a peripheral IV catheter as part of their ...
Breaking Medicine News(10 mins):
(Date:4/28/2017)... Inc. ("Hill-Rom") (NYSE: HRC ) today ... ended March 31, 2017, and raised its outlook ... guidance reflect the contribution from the Mortara Instrument ... 14, 2017.  For the fiscal second ... share compared to $0.33 per diluted share in ...
(Date:4/26/2017)... Phoenix Marketing Solutions ( Phoenix ) ... mission of transforming science into clinical practice. During a time ... innovative approach supports the life sciences industry by ... in science and medicine — which ultimately improves lives. ... 2002 by Tracy Doyle and Angela Fiordilino ...
(Date:4/25/2017)... Endo International plc (NASDAQ: ENDP ) will announce its ... management team will host a conference call and webcast before the ... The dial-in number to access the call is U.S./ Canada ... 6086379. Please dial in 10 minutes prior to the scheduled start ... call will be available from May 9, 2017 at 11:30 a.m. ...
Breaking Medicine Technology: